Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  KHRNF | KHRWF | V.KHRN.WT.H

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

Recent & Breaking News (TSXV:KHRN.H)

Khiron successfully completes first medical cannabis sale in Brazil

PR Newswire July 2, 2021

Vicente Fox, Khiron Board Member and Former President of Mexico, Applauds Mexican Supreme Court's Advancement of Cannabis Laws

PR Newswire June 30, 2021

Khiron Accelerates Entry into Mexico, Awarded High-THC Extract Export Quotas for Mexico by the Government of Colombia

PR Newswire June 28, 2021

Khiron provides European management updates

Canada NewsWire June 14, 2021

Khiron Opens First Zerenia(TM) Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients

Canada NewsWire June 10, 2021

Khiron receives its largest European medical cannabis shipment to date

Canada NewsWire June 8, 2021

Khiron Life Sciences Corp.: Invitation to the Benzinga Virtual Cannabis Capital Conference

Newsfile June 1, 2021

Khiron Announces Upcoming Investor Events and Grant of Options and Restricted Share Units

Canada NewsWire May 31, 2021

Khiron Life Sciences Reports First Quarter 2021 Financial Results

Canada NewsWire May 27, 2021

Khiron Partners with Colombia Cancer League to Deliver 3,000 Medical Cannabis Patient Consultations

Canada NewsWire May 25, 2021

Khiron to Host First Quarter 2021 Conference Call on May 28, 2021

Canada NewsWire May 19, 2021

Khiron Life Sciences Corp.: Invitation to the Q2 Virtual Investor Summit

Newsfile May 12, 2021

Khiron Comments on the Results of Project Twenty21 - UK´s Largest Observational Study into Medical Cannabis Products

Canada NewsWire May 11, 2021

Khiron to Present at Canaccord Genuity's Virtual Cannabis Conference

Canada NewsWire May 6, 2021

Khiron Life Sciences Reports 2020 Fiscal Year End Results and Provides Corporate Update

Canada NewsWire April 29, 2021

Khiron Receives Accreditation for UK Medical Cannabis Education and Partners with UK's Cellen Therapeutics to Improve Clinician Education

Canada NewsWire April 13, 2021

Khiron Expands Product Offering in UK and Increases Patient Access

Canada NewsWire April 7, 2021

Khiron Medical Cannabis Products Arrive in Germany for Immediate Prescription, Sale and Distribution

Canada NewsWire March 22, 2021

Khiron Updates Zerenia(TM) Expansion Program; Announces Plans to Open Three Additional Satellite Clinics in Colombia by End of Q2

PR Newswire March 18, 2021

Khiron Life Sciences Corp. To Present At The Q1 Virtual Investor Summit

GlobeNewswire March 11, 2021